1. Home
  2. FOR vs VIR Comparison

FOR vs VIR Comparison

Compare FOR & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Forestar Group Inc

FOR

Forestar Group Inc

HOLD

Current Price

$27.79

Market Cap

1.4B

Sector

Finance

ML Signal

HOLD

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

HOLD

Current Price

$9.56

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FOR
VIR
Founded
2005
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.5B
IPO Year
2007
2019

Fundamental Metrics

Financial Performance
Metric
FOR
VIR
Price
$27.79
$9.56
Analyst Decision
Buy
Strong Buy
Analyst Count
3
7
Target Price
$32.67
$19.43
AVG Volume (30 Days)
121.2K
1.4M
Earning Date
04-21-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
17.49
EPS
0.93
N/A
Revenue
$1,662,400,000.00
$68,556,000.00
Revenue This Year
$0.34
$270.22
Revenue Next Year
$7.73
N/A
P/E Ratio
$29.49
N/A
Revenue Growth
10.14
N/A
52 Week Low
$18.73
$4.16
52 Week High
$30.74
$11.66

Technical Indicators

Market Signals
Indicator
FOR
VIR
Relative Strength Index (RSI) 58.69 51.45
Support Level $24.22 $8.48
Resistance Level $29.05 $10.29
Average True Range (ATR) 0.84 0.42
MACD 0.12 0.04
Stochastic Oscillator 85.00 69.78

Price Performance

Historical Comparison
FOR
VIR

About FOR Forestar Group Inc

Forestar Group Inc is a residential lot development company engaged in land acquisition and development for the sale of finished single-family residential lots to local, regional, and national homebuilders. The company operates through a single real estate segment, which acquires land, installs infrastructure for residential communities, and generates all revenue from lot sales. Its communities mainly support entry-level, first-time move-up, and active-adult homes, with certain communities also marketed to build-to-rent operators. The company generally invests in entitled, short-duration projects that can be developed in phases to align lot production with market demand and support efficient capital deployment.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.

Share on Social Networks: